A Better Therapeutics Inc. shareholder sued the architects of its blank-check transaction, claiming the deal’s lopsided structure gave insiders a huge windfall despite virtually wiping out public investors.
The lawsuit targets the Mountain Crest Capital LLC affiliates who engineered the $187 million merger between Better Therapeutics and a special purpose acquisition company. Mountain Crest and its principals are serial SPAC sponsors whose previous ventures include the blank-check deal that took Playboy public.
The dispute in Delaware’s Chancery Court is the latest in a wave of investor litigation prompted by transactions that give private businesses a shortcut to capital markets through ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.